Hospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (206)

2024

  1. Association of intravenous digoxin use in acute heart failure with rapid atrial fibrillation and short-term mortality according to patient age, renal function, and serum potassium

    European Journal of Emergency Medicine, Vol. 31, Núm. 5, pp. 347-355

  2. Atención primaria y péptidos natriuréticos: diseño de un proceso asistencial para la mejora en el diagnóstico de la insuficiencia cardiaca

    Semergen: revista española de medicina de familia, Núm. 7

  3. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  4. Effect of early initiation of noninvasive ventilation in patients transported by emergency medical service for acute heart failure

    European Journal of Emergency Medicine, Vol. 31, Núm. 5, pp. 339-346

  5. Effect of seasonal influenza and COVID-19 vaccination on severity and long-term outcomes of patients with heart failure decompensations

    European Journal of Heart Failure

  6. Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias (North Spain)

    Clinical Genetics, Vol. 106, Núm. 4, pp. 525-531

  7. Identification of host endotypes using peripheral blood transcriptomics in a prospective cohort of patients with endocarditis

    International Journal of Infectious Diseases, Vol. 148

  8. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182

  9. Insights into the Evolution of IncR Plasmids Found in the Southern European Clone of the Monophasic Variant of Salmonella enterica Serovar Typhimurium

    Antibiotics, Vol. 13, Núm. 4

  10. Mediterranean Diet Prior to Ischemic Stroke and Potential Circulating Mediators of Favorable Outcomes

    Nutrients , Vol. 16, Núm. 18

  11. No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

    Scientific Reports, Vol. 14, Núm. 1